Citation Impact
Citing Papers
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
2019 Standout
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Immune Rejection of Mouse Tumors Expressing Mutated Self
2009 StandoutNobel
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients.
1989
Malignant pheochromocytoma: current status and initiatives for future progress
2004
Atopic Dermatitis
2008 Standout
Hereditary Paraganglioma/Pheochromocytoma and Inherited Succinate Dehydrogenase Deficiency
2005
A view on drug resistance in cancer
2019 StandoutNature
Kinetics and characterization of intercellular adhesion molecule-1 (ICAM-1) expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphomas
1989
Repopulation of cancer cells during therapy: an important cause of treatment failure
2005
Cell production rates in human tissues and tumours and their significance. Part II: clinical data
2000
Sjögren's syndrome
2005 Standout
Chromosomal Aberration Patterns Differ in Subtypes of Primary Cutaneous B Cell Lymphomas
2004
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas
2004
Classification of Cutaneous Lymphoma
1999
Cd30+ cutaneous lymphoproliferative disorders: The stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma
2003
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses in vitro
2006
Imaging in the era of molecular oncology
2008 StandoutNature
Phaeochromocytoma
2005 Standout
Head and neck cancer
2008 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Nasopharyngeal carcinoma
2019 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
2016
The management of benign and malignant pheochromocytoma and abdominal paraganglioma
2003
Primary Cutaneous T-Cell–Rich B-Cell Lymphoma: Clinically Distinct from Its Nodal Counterpart?
2001
Neurogenesis in the adult human hippocampus
1998 Standout
Molecular Cytogenetic Analysis of Chromosomal Breakpoints in the IGH, MYC, BCL6, and MALT1 Gene Loci in Primary Cutaneous B-cell Lymphomas
2004
Primary Cutaneous Diffuse Large B-Cell Lymphoma
2002
Membrane vesicles as conveyors of immune responses
2009 Standout
Hyperfractionated Accelerated Radiotherapy for T1,2 Glottic Carcinoma
2008
Major Salivary Gland Imaging
2000
Immune surveillance of tumors
2007
Human Interleukin-10 Expression in T/Natural Killer-Cell Lymphomas
1998
Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers
2009
A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation
1999
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
1995
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
2011
Nasopharyngeal carcinoma
2015 Standout
Primary cutaneous T‐cell lymphoma: Clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and cd30‐positive large cell lymphoma
1994
Immunity, Inflammation, and Cancer
2010 Standout
Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance
2003
CD4+ CD56+ Cutaneous Neoplasms: A Distinct Hematological Entity?
1999
A systematic review of humoral immune responses against tumor antigens
2009
World Health Organization classification of hematopoietic and lymphoid tissues: Implications for dermatology
2003
Adhesion receptors of the immune system
1990 StandoutNature
Immune surveillance in the skin: mechanisms and clinical consequences
2004
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Epstein–Barr virus: 40 years on
2004 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Primary Cutaneous Diffuse Large B-cell Lymphoma
2003
Therapy of Cutaneous Lymphoma – Current Practice and Future Developments
2003
Cancer immunotherapy comes of age
2011 StandoutNature
Head and Neck Cancer
1993 Standout
Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy
1998
Large B-cell lymphoma of the leg: clinical and pathologic characteristics in a north american series
2003
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
2013 Standout
Primary Cutaneous CD4+ Small-/Medium-Sized Pleomorphic T-Cell Lymphoma: A Cutaneous Nodular Proliferation of Pleomorphic T Lymphocytes of Undetermined Significance? A Study of 136 Cases
2009
CD69, HLA-DR and the IL-2R Identify Persistently Activated T Cells in Psoriasis Vulgaris Lesional Skin: Blood and Skin Comparisons by Flow Cytometry
2000
Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
1991
Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell Markers
2008
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
2004
Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma
2015
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Pheochromocytoma: Update on Diagnosis, Localization, and Management
1995
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature
2004
The biologic importance of tumor‐infiltrating lymphocytes
2010
The value of plasma markers for the clinical behaviour of phaeochromocytomas
2002
Co‐expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases
2000
A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer
1997
Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma.
1998
Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior
2008
Angiogenesis as a therapeutic target
2005 StandoutNature
Subcutaneous, Blastic Natural Killer (NK), NK/T-cell, and Other Cytotoxic Lymphomas of the Skin: A Morphologic, Immunophenotypic, and Molecular Study of 50 Patients
2004
Tumours of familial origin in the head and neck
2006
Head and Neck Cancer
2001 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Epstein–Barr Virus Infection
2000 Standout
Hyperprogressive disease: recognizing a novel pattern to improve patient management
2018
Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients.
1998
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics
1995
A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers
1999
Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A Comparison of the European Organization for Research and Treatment of Cancer and the WHO Classification Systems
2004
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: clinicopathological findings of four cases
1998
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Regulatory T Cells and Human Disease
2020 StandoutNobel
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
1999 StandoutNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment
2000
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Nonviral Vectors for Gene Delivery
2008 Standout
Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling
2004
Natural Killer/Natural Killer-Like T-Cell Lymphoma, CD56+, Presenting in the Skin: An Increasingly Recognized Entity With an Aggressive Course
2001
Treatment of Multifocal Primary Cutaneous B-Cell Lymphoma: A Clinical Follow-Up Study of 29 Patients
1999
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics
1995
Quantitative Imaging in Cancer Evolution and Ecology
2013
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
Primary Chemotherapy in Resectable Oral Cavity Squamous Cell Cancer: A Randomized Controlled Trial
2003
Primary Cutaneous Small/Medium CD4+ T-Cell Lymphomas: A Heterogeneous Group of Tumors With Different Clinicopathologic Features and Outcome
2008
Nonnasal Lymphoma Expressing the Natural Killer Cell Marker CD56: A Clinicopathologic Study of 49 Cases of an Uncommon Aggressive Neoplasm
1997
Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics.
1989
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization.
1998
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Molecular Genetics of Head and Neck Cancer
2002
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
2017
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients
2002
Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer.
2000
p53 Antibodies in the sera of patients with various types of cancer: a review.
2000
SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
2006
Blood diffusion and Th1-suppressive effects of galectin-9–containing exosomes released by Epstein-Barr virus–infected nasopharyngeal carcinoma cells
2008
Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial
2006
Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients
2003
Inhibitory effect of tumor cell–derived lactic acid on human T cells
2007
Works of J. Bosq being referenced
In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy
1993
Statistical Evaluation of Diagnostic and Prognostic Features of CD30+ Cutaneous Lymphoproliferative Disorders
1998
Analysis of p53 Serum Antibodies in Patients With Head and Neck Squamous Cell Carcinoma
1996
Malignant pheochromocytoma: Clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases
1992
Expression of the Epstein-Barr Virus Immediate Early Gene, BZLF1, in Nasopharyngeal Carcinoma Tumor Cells
1993
Adenoid cystic carcinoma of the head and neck: evaluation with MR imaging and clinical-pathologic correlation in 27 patients.
1992
Paragangliomas of the Head and Neck
1991
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
1994
Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity
2005
Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks
1996
Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer
1994
In situ T-cell responses in a primary regressive melanoma and subsequent metastases: A comparative analysis
1997
Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.
1993
Squamous cell carcinoma of the pyriform sinus: Retrospective study of 351 cases treated at the institut Gustave‐Roussy
1987
Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.
1986
Prognostic Factors in Primary Cutaneous Large B-Cell Lymphomas: A European Multicenter Study
2001
Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
1993
Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence.
1997
Factor analysis of medical image sequences in MR of head and neck tumors.
1994
Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates
1987
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas.
1999